Semaglutide as a promising treatment for metabolic dysfunction‑associated steatotic liver disease. JMS [Internet]. 2025 Mar. 31 [cited 2025 Aug. 17];94(1):e1219. Available from: https://horkruks.ump.edu.pl/index.php/JMS/article/view/1219